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Trends in Biotechnology  
Opportunities and Threats for Developing Countries!? 
 
 
Abstract: Biotechnology is one of the “hot spots” in research and development in this century. Great 
chances and opportunities lie ahead, but also tremendous threats. While technology and knowledge is easily 
available all over the world, it can be quite difficult to access markets and to commercialize biotechnological 
products. What are the main obstacles? What are the newest scientific insights? How can developing 
countries bring biotechnology successfully to the market?  
 
 
 
Biotechnology, regardless of red, green or white 
biotechnology, promises high profits. However, 
the field is also complex, fast moving and costly. 
Especially in the field of medical applications there 
are many risks associated with biotechnology. One 
example is a drug developed against multiple 
sclerosis, which had possible profits of 3$ billion. 
After two patients developing a rare brain disease 
in clinical trials the profits vaporized and the stock 
market were in an uproar. Nevertheless does the 
United Nations Development Program see 
“biotechnology innovation and globalization as a 
means of helping the poor of the world live fuller, 
richer and more secure lives”. Only through 
commercialization this promise will come true. 
 
 
 
 
Commercialization is converting or moving 
technology into a profit making position [1]. What 
are the major problems? How to commercialize 
biotechnology best? And as most research in this 
area focuses on either the US or Europe: What are 
the specific problems companies and institutes in 
developing countries face? 
In our opinion the most important point is to 
bridge the gap between technology and markets. 
The matching of technological challenge and 
market challenge is difficult and many tools have 
been developed to address this problem [2]. Why 
does this problem still exist?  
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First of all there is always a difference in doing 
business and doing science. And second, taking 
into account the enormous amounts of 
publications in the field of biotechnology each 
year, it is obvious that it is very difficult to keep up 
with the fast moving technology on the one hand 
and the market developments on the other. In an 
extreme case, e.g. nutraceuticals, you have both the 
fast moving biotechnology and the fast moving 
food market.  
In this Special Issue of the “Journal of Business 
Chemistry” we address the problems of 
biotechnology, especially in Latin American 
countries like Cuba or Brazil.  
The 14th International Scientific Congress 
CNIC 2005 in Cuba – with many sessions devoted 
to biotechnology and the commercialization of it – 
gave a good overview of the developments in this 
field. This Congress was organized by the Cuban 
National Center for Scientific Research (CNIC), 
which was founded in 1965. Currently it is devoted 
to scientific research in important fields like 
natural, biomedical and technological sciences.  
This Congress (from June 27th to 30th) had as 
a slogan “40 Years at the Service of Science and 
Technology“ and was an ideal space for meeting 
foreign (250 delegates) and national (600 delegates) 
specialists in different fields of scientific research. 
Many research topics were discussed, to mention 
just a few: Natural Products from Plants and 
Phytotherapeutical  Products, II Symposium on 
Infectious Diseases: Vaccines and Adjuvants, 
Diagnosis, Immunology, Molecular Biology and 
Proteomics, Systems for Fast Diagnosis in 
Microbiology and the First International 
Symposium on Scientific-Technological Prospects. 
From this International Conference very few 
papers were selected and then again reviewed by 
the “Journal of Business Chemistry”.  
 
Although there were many good works, we 
could not take all articles. We tried to get a very 
varied overview of the topic from a scientific, 
commercial and social point of view and thank all 
authors for their great contributions.  
This Special Issue (Vol. 2, Issue 3) on 
Biotechnology of the “Journal of Business 
Chemistry” will give some new insights into 
protein expression and its possible use in disease 
treatment, as well as an example of a political 
initiative in Brazil to foster nano- and 
biotechnology. We also present articles with some 
interesting patent analysis and others, which give a 
theoretical social and techno-economic point of 
view.  
For the first time, we also have a commentary 
section in the “Journal of Business Chemistry” 
where people can discuss their opinion in certain 
fields connected to the articles presented.                              
For us it seems clear that one can only be 
successful in “bringing biotechnology to the 
market” by cooperating with others. This might be 
true especially for small companies and companies 
in developing countries. First, firms should 
develop a sense of what they can do best and what 
their strategy is. Second, they should find the right 
partner for fulfilling the aims. Thus biotechnology 
might yield high profits for all! 
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Now enjoy reading the Special Issue of the Journal of Business Chemistry in 2005. If you have any comments 
or suggestions, please send us an e-mail to contact@businesschemistry.org. 
       
 Stefan Picker and Beatriz Garcia 
